Blood Viscometer Market Report 2024

This Blood Viscometer market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The blood viscometer market size has grown strongly in recent years. It will grow from $1.6 billion in 2023 to $1.69 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth observed during the historical period can be attributed to several key factors, including advancements in diagnostic technology, a heightened focus on diabetes management, growing awareness of blood disorders, an aging population, and the development of personalized medicine.

The blood viscometer market size is expected to see strong growth in the next few years. It will grow to $2.1 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The projected growth during the forecast period can be attributed to several factors, including the introduction of portable viscometers, a growing focus on preventive healthcare, the expansion of point-of-care testing, increasing investments in healthcare infrastructure, and growth in clinical research and drug development. Key trends expected to influence this period include the integration of digital and smart technologies, a rising demand for non-invasive testing solutions, increased application in chronic disease management, the development of automated viscometers, and heightened research efforts in blood disorders and related therapies.

The increasing prevalence of cardiovascular disease is projected to drive the growth of the blood viscometer market in the coming years. Cardiovascular disease encompasses a range of disorders that affect the heart and blood vessels, frequently resulting in serious conditions such as heart attacks, strokes, or other heart-related complications. The rise in cardiovascular disease is primarily attributed to lifestyle factors, including poor dietary habits, physical inactivity, smoking, and the escalating rates of obesity and diabetes, compounded by aging populations. Blood viscometers are essential tools in cardiovascular disease management, as they measure blood viscosity, which indicates how thick or thin the blood is. This measurement is critical because it influences circulation and can heighten the risk of conditions such as heart attacks, strokes, and blood clots. For example, a report from the American College of Cardiology, published in August 2022, indicated that all four major cardiovascular risk factors in the United States are projected to rise significantly from 2025 to 2060. Notably, diabetes is anticipated to experience the most substantial increase, with a projected rise of 39.3% to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Thus, the growing prevalence of cardiovascular disease is a key driver for the blood viscometer market.

Prominent companies in the blood viscometer market are concentrating on the development of innovative products, such as automated viscometers, to gain a competitive advantage. An automated viscometer is designed to measure the viscosity of liquids automatically, eliminating the need for manual intervention. A notable example is the INVI viscometer launched by Sofraser, a France-based electronics manufacturer, in March 2023. This device features a compact, inline design that allows for continuous, real-time viscosity measurement without the need for manual sampling. It is built to be highly durable, delivering accurate results even under extreme industrial conditions, and offers maintenance-free operation with minimal wear and tear. Additionally, the INVI viscometer can be seamlessly integrated into existing systems, enhancing process control.

In August 2023, Anton Paar AG, an Austria-based laboratory instrument provider, acquired Brabender GmbH & Co. KG for an undisclosed amount. This acquisition is expected to enable Anton Paar AG to broaden its portfolio with advanced viscometry and rheometry solutions, thereby reinforcing its position in the precision measurement market. Brabender GmbH & Co. KG, located in Germany, specializes in providing viscometers.

Major companies operating in the blood viscometer market are Thermo Fisher Scientific Inc., Emerson Electric Co, Xylem Analytics, PerkinElmer Inc., Qualitest, Anton Paar GmbH, AMETEK Brookfield, BYK Gardner, PAC LP., CANNON Instrument Company, Koehler Instrument Company Inc., PCE Instruments, RheosenseInc., Orbit Research Associates Pvt. Ltd., Swastik Systems & Services, Lamy Rheology, Fann Instrument Company, Labomat Essor., Edutek Instrumentation, Lasany International.

North America was the largest region in the blood viscometer market in 2023. The regions covered in the blood viscometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the blood viscometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A blood viscometer is a specialized device used to measure the viscosity, or thickness and flow resistance, of blood. This measurement is essential for assessing blood flow dynamics, which is critical for understanding circulation and diagnosing various health conditions. By offering insights into the physical properties of blood, it aids in monitoring diseases such as cardiovascular disorders and diabetes.

The primary types of blood viscometers include rotational viscometers, capillary viscometers, and other variants. Rotational viscometers operate by rotating a spindle or disc within a blood sample to measure its viscosity. Applications of blood viscometers encompass blood viscosity measurement, plasma viscosity measurement, and other related assessments. These devices are utilized by a range of end users, including hospitals, diagnostic centers, research institutes, and other healthcare facilities.

The blood viscometer market research report is one of a series of new reports that provides blood viscometer market statistics, including blood viscometer industry global market size, regional shares, competitors with a blood viscometer market share, detailed blood viscometer market segments, market trends and opportunities, and any further data you may need to thrive in the blood viscometer industry. This blood viscometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood viscometer market consists of sales of falling ball viscometers, ultrasonic viscometers, oscillating viscometers, and electromagnetic viscometers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.